|
Jul 29
|
Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024
|
|
Jun 24
|
Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?
|
|
May 16
|
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
|
|
May 15
|
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
|
|
May 10
|
Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago
|
|
May 8
|
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
|
|
Apr 16
|
14 Cheap Penny Stocks to Buy According to Analysts
|
|
Mar 17
|
Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
|
|
Mar 15
|
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript
|
|
Mar 15
|
Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
|
|
Mar 14
|
Q4 2023 Spero Therapeutics Inc Earnings Call
|
|
Mar 13
|
Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates
|
|
Mar 13
|
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
|
|
Mar 6
|
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
|
|
Feb 6
|
Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares
|
|
Jan 2
|
Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
|
|
Aug 22
|
Down -11.72% in 4 Weeks, Here's Why Spero Therapeutics, Inc. (SPRO) Looks Ripe for a Turnaround
|
|
Apr 28
|
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|